Contemporary Outcomes of Chorionic Villus Sampling from the First Trimester to Neonatal Follow-Up

Öztürk FH, Öcal FD, Erol SA, et al. Fetal genetic diagnosis by chorionic villus sampling: evaluation of the five-year experience from a single center. Fetal Pediatr Pathol. 2021;40:281-9.

Practice Bulletin No. 162: Prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127:e108-e22.

Ghi T, Sotiriadis A, Calda P, et al; International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). ISUOG Practice Guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol. 2016;48:256-68.

Navaratnam K, Alfirevic Z; Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8 July 2021: Green-top Guideline No. 8. BJOG. 2022;129:e1-e15.

Torun R, Sever B, Tuncer Can S, Sağlam C, Özer M, Emiralioğlu Çakır Z. Analysis of amniocentesis results in a tertiary care center: a retrospective cohort study. Forbes J Med. 2024;5:129-34.

Dikensoy E, Cebesoy FB, Öztürk E, Uğur MG, Balat Ö, Kutlar Aİ. Initial chorionic villus sampling results of Gaziantep University: one year analysis. Turk J Obstet Gynecol. 2010;7:267-72.

Jorge P, Mota-Freitas MM, Santos R, Silva ML, Soares G, Fortuna AM. A 26-year experience in chorionic villus sampling prenatal genetic diagnosis. J Clin Med. 2014;3:838-48.

Bilen E, Yüksel M, Köse S, Tola E, Sezik M. Gebeliğin 11-14 haftasında karyotipleme amaçlı koryon villüs biyopsisi: 42 olgunun değerlendirilmesi. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi. 2015;6:1-3.

Kuyucu M, Erdogan KM, Adiyaman D, et al. Consecutive 5-year outcomes of chorionic villus sampling at a tertiary center. Medicine (Baltimore). 2025;104:e41582.

Chevreau J, Becart L, Sergent F, Foulon A, Gondry J, Jedraszak G. Risk factors for failed chorionic villus sampling: results of a 4-year retrospective study. J Matern Fetal Neonatal Med. 2022;35:141-6.

Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16-26.

Martins AT, Francisco C, Correia H, Cohen Á. Chorionic villus sampling: 10 years of experience in a university referral center. J Gynecol Obstet Hum Reprod. 2020;49:101715.

Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol. 2007;110:687-94. Erratum in: Obstet Gynecol. 2008;111:779.

AIUM-ACR-ACOG-SMFM-SRU practice parameter for the performance of standard diagnostic obstetric ultrasound examinations. J Ultrasound Med. 2018;37:E13-E24.

International Society of Ultrasound in Obstetrics and Gynecology; Bilardo CM, Chaoui R, Hyett JA, et al. ISUOG Practice Guidelines (updated): performance of 11-14-week ultrasound scan. Ultrasound Obstet Gynecol. 2023;61:127-43.

Sikkema-Raddatz B, Bouman K, Verschuuren-Bemelmans CC, et al. Four years’ cytogenetic experience with the culture of chorionic villi. Prenat Diagn. 2000;20:950-5.

Manegold-Brauer G, Kang Bellin A, Hahn S, et al. A new era in prenatal care: non-invasive prenatal testing in Switzerland. Swiss Med Wkly. 2014;144:w13915.

Manegold-Brauer G, Berg C, Flöck A, Rüland A, Gembruch U, Geipel A. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Arch Gynecol Obstet. 2015;292:543-8.

Dungan JS, Klugman S, Darilek S, et al. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023;25:100336. Erratum in: Genet Med. 2023;25:100874.

Tuncer Can S, Golbasi H, Bayraktar B, et al. Prenatal findings and perinatal outcomes of rare autosomal trisomies: a retrospective cohort study. Fetal Pediatr Pathol. 2025;44:357-71.

Benn P, Malvestiti F, Grimi B, Maggi F, Simoni G, Grati FR. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples. Ultrasound Obstet Gynecol. 2019;54:458-67.

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459-67.

Beksaç MS, Unal C, Tanacan A, Fadiloglu E, Çakar AN. Chorionic villus sampling experience of a reference perinatal medicine center. Ann Hum Genet. 2020;84:229-34.

Hopkins MK, Dugoff L, Kuller JA. Spinal muscular atrophy: inheritance, screening, and counseling for the obstetric provider. Obstet Gynecol Surv. 2021;76:166-9.

Turkey SMA Foundation. For combating SMA disease and healthy tomorrows. Available from: https://www.sma.org.tr/en/carrier-scan

Sun Y, Kong X, Zhao Z, Zhao X. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China. BMC Med Genet. 2020;21:133.

Shariati M, Davoudi A, Boostani R, et al. The prevalence of SMN gene deletion/duplication in spinal muscular atrophy families referred to neuro-genetic centers of Mashhad, Iran. Egypt J Med Hum Genet. 2024;25:87.

Mežnarić S, Belančić A, Rački V, Vitezić D, Mršić-Pelčić J, Pilipović K. Prenatal management of spinal muscular atrophy in the era of genetic screening and emerging opportunities in ın utero therapy. Biomedicines. 2025;13:1796.

Beksac MS, Yurter H, Tanacan A, et al. Gestational outcomes of pregnant women who have had invasive prenatal testing for the prenatal diagnosis of spinal muscular atrophy. S Afr J Obstet Gynaecol 2018;24:15.

Papp C, Beke A, Mezei G, Tóth-Pál E, Papp Z. Chorionic villus sampling: a 15-year experience. Fetal Diagn Ther. 2002;17:218-27.

Akolekar R, Bower S, Flack N, Bilardo CM, Nicolaides KH. Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling. Prenat Diagn. 2011;31:38-45.

Zelig CM, Knutzen DM, Ennen CS, Dolinsky BM, Napolitano PG. Chorionic villus sampling, early amniocentesis, and termination of pregnancy without diagnostic testing: comparison of fetal risk following positive non-invasive prenatal testing. J Obstet Gynaecol Can. 2016;38:441-5.e2.

Movahedi M, Farahbod F, Zarean E, Hajihashemi M, Haghollahi F, Farahmand M. Evaluation of fetal and maternal outcomes in chorion villus sampling (CVS). Adv Biomed Res. 2023;12:133.

Shahbazian N, Barati M, Arian P, Saadati N. Comparison of complications of chorionic villus sampling and amniocentesis. Int J Fertil Steril. 2012;5:241-4.

Vera-Ponce VJ, Loayza-Castro JA, Ballena-Caicedo J, Valladolid-Sandoval LAM, Zuzunaga-Montoya FE, Gutierrez De Carrillo CI. Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: a systematic review and meta-analysis. Front Reprod Health. 2025;7:1706009.

Kim N, Joo EH, Kim S, et al. Comparative analysis of obstetric, perinatal, and neurodevelopmental outcomes following chorionic villus sampling and amniocentesis. Front Med (Lausanne). 2024;11:1407710.